Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm.

Clinical chemistry and laboratory medicine - 27 Sept 2021

De Bruyne Sander, Steel Eva, Petrick Marjan, Denys Barbara, Vandepoele Karl, Van Roy Nadine, Degandt Simon, Ghys Timothy, Louagie Henk

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Janus Kinase 2
Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloproliferative Disorders

Source

Identifiers

PMID: 33964201
DOI: 10.1515/cclm-2020-1884

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm.PMID 33964201Read ↗

Mutations and chromosomal rearrangements of JAK2: not only a myeloid issue.Semantic proximity Read ↗

Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the LiteratureSemantic proximity Read ↗

JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.Semantic proximity Read ↗

Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.Semantic proximity Read ↗

BCR/ABL-negative chronic myeloproliferative disorders: JAK2 mutation and beyond.Semantic proximity Read ↗

Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm.Semantic proximity Read ↗

JAK2-positive myeloproliferative neoplasm co-existing with systemic mastocytosis.Semantic proximity Read ↗

Emergence of Chronic Myelogenous Leukemia From a Background of Myeloproliferative Disorder: JAK2V617F as a Potential Risk Factor for BCR-ABL TranslocationSemantic proximity Read ↗

Two cases of myeloproliferative neoplasm with a concurrent JAK2 (V617F) mutation and BCR/ABL translocation without chronic myelogenous leukemia phenotype acquisition during hydroxyurea treatment.Semantic proximity Read ↗

Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.Semantic proximity Read ↗

JAK2 mutation and atypical chronic myeloid leukemia.Semantic proximity Read ↗

JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.